| Stage | INVX | % of rev | GHM | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $265M | 100.00% | $71M | 100.00% | INVX ×3.72 |
| Gross profit | $96M | 36.17% | $18M | 24.95% | INVX +11.2pp |
| Operating income | $32M | 12.20% | $4M | 5.82% | INVX +6.4pp |
| Pre-tax income | $35M | 13.12% | $4M | 5.86% | INVX +7.3pp |
| Net income | $26M | 9.92% | $4M | 5.48% | INVX +4.4pp |
| Stage | INVX | GHM | Gap · A − B |
|---|---|---|---|
| Revenue | $265M100.00% | $71M100.00% | INVX ×3.72 |
| Gross profit | 36.17%$96M | 24.95%$18M | INVX +11.2pp |
| Operating income | 12.20%$32M | 5.82%$4M | INVX +6.4pp |
| Pre-tax income | 13.12%$35M | 5.86%$4M | INVX +7.3pp |
| Net income |
| 9.92%$26M |
| 5.48%$4M |
| INVX +4.4pp |
No disclosed counterparties: GHM.
None